Susan Morse

A strong MFN law could be a meaningful step toward bringing U.S. prices in line with those paid by other high-income countries, says Patients for Affordable Drugs Now.

Physicians tell Dr. Amy Bucher they feel a sense of empowerment in being able to offer patients something that, along with lifestyle changes, reduces weight, lowers the risk of diabetes and high blood pressure, and helps prevent other chronic conditions.

Revenue growth will come from clinical outcomes versus document mechanics, says Steve Mongelli, president at mPulse.

Amazon is competing with Walmart in the delivery business and against pharmacies such as CVS and Walgreens.

HHS is looking at how the care plan is supporting the patient, says Sandy Griffiths, senior product manager for Homecare Homebase.

Patients can see the discounted prices on TrumpRx.gov, but the site does not currently sell the drugs.

The minibus package also funds HHS and extends acute hospital care at home.

The $600M in no-cost and discounted technology products and services will also aid in the broader modernization of Medicaid systems, CMS says.

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.

In the best case scenario, hospitals “are getting 20% less than the lowest workman’s comp fee schedule in the country,” says Zachary Schultz of EnableComp.